India Ophthalmology Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The India Ophthalmology Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), End-User (Hospitals, Specialty Ophthalmic Clinics, and More. The Market Forecasts are Provided in Terms of Value (USD).

India Ophthalmology Devices Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of India Ophthalmology Devices Market with other markets in Healthcare Industry

India Ophthalmology Devices Market Analysis by Mordor Intelligence

The Indian ophthalmic devices market size is valued at USD 1.49 billion in 2024 and is forecast to reach USD 2.21 billion by 2030, advancing at a 6.91% CAGR between 2025 and 2030. Robust public‐health funding, rising digital‐screen exposure, and a widening pool of older adults are aligning to create a broad, stable demand base that shields the Indian ophthalmic devices market from short-term economic swings. The National Programme for Prevention and Control of Blindness (NPCB) and the Ayushman Bharat Health Infrastructure Fund (AB-HIF) together underwrite large‐scale device procurements, while private hospitals and ambulatory surgery centres chase premium technologies to attract urban patients. Indigenous start-ups now introduce frugal innovations that undercut traditional import prices by up to 50%, prompting global brand owners to localise production and re-engineer mid-tier platforms for the Indian ophthalmic devices market. Competitive intensity is pivoting from pure hardware credentials to service uptime, clinician training, and digital connectivity, signalling a maturity arc that historically took longer to unfold in comparable emerging markets.

Key Report Takeaways

  • By device type, vision care devices led with 63.71% Indian ophthalmic devices market share in 2024, whereas diagnostic & monitoring devices are projected to expand at a 9.03% CAGR through 2030.
  • By disease indication, cataract solutions captured 39.61% share of the Indian ophthalmic devices market size in 2024, while diabetic-retinopathy products are positioned to grow at an 8.20% CAGR to 2030.
  • By end-user, hospitals accounted for 45.91% of the Indian ophthalmic devices market size in 2024; ambulatory surgery centres are expected to post the fastest 8.05% CAGR during 2025-2030.

Segment Analysis

By Device Type: Vision Care Dominance and Diagnostic Acceleration

Vision Care Devices, ranging from frames to automated lens edging systems, held 63.71% Indian ophthalmic devices market share in 2024. The rise of organised retail chains and corporate wellness programmes drives demand for quick refraction tools and lens-coating units that allow same-visit dispensing. Parallel e-commerce platforms funnel online shoppers into stores for final fittings, boosting traffic for objective refraction kiosks. AI-enabled lens-measurement apps further compress consultation times, increasing throughput without large capital spend.

Diagnostic & Monitoring Devices are on track for a 9.03% CAGR because portable OCT scanners, smartphone-linked fundus cameras, and home tonometry kits blend affordability with clinical precision. Regulatory acceptance of offline AI, illustrated by the CDSCO nod to Remidio’s Medios DR AI in 2024, enhances clinician confidence. Investment flows into cloud platforms that analyse imaging data, trading upfront hardware margins for subscription revenues. Surgical Devices remain smaller but capture high-value spend as FLACS and microincision vitrectomy units replace legacy phaco systems in referral hospitals. Suppliers leverage service contracts that guarantee 95% uptime, embedding loyalty and recurring part sales into the Indian ophthalmic devices market size calculus.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Disease Indication: Cataract Volume and Diabetic Retinopathy Velocity

Cataract equipment retains the largest slice of Indian ophthalmic devices market size at 39.61% because public hospitals must meet surgery targets set under NPCB. High-volume district centres prefer dual-phaco workstations that permit parallel cases, lifting daily throughput. Disposable injector systems and foldable intraocular lenses account for the bulk of consumable spend, sustaining manufacturer service footprints in semi-urban belts.

Diabetic retinopathy solutions promise an 8.20% CAGR as India hosts more than 101 million diabetics. Early-stage screening now migrates into primary clinics and mobile vans, empowering non-ophthalmologists to capture retinal images. AI algorithms triage cases by severity, freeing scarce specialists for complex interventions. Glaucoma and age-related macular degeneration segments follow behind yet harvest incremental demand through minimally invasive implants and sustained-release drug dispensers, nudging cross-selling opportunities across the Indian ophthalmic devices market.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By End-user: Hospital Scale Meets ASC Agility

Hospitals captured 45.91% of the Indian ophthalmic devices market size in 2024, driven by their capacity to host complex multi-specialty clinics and obtain AB-HIF grants for operating-theatre upgrades. Digital imaging suites link operating rooms to teaching auditoriums, reinforcing hospitals’ role as talent hubs and service referral nodes. Specialty ophthalmic clinics place second; their nimble governance lets them trial AI triage tools sooner, expanding patient rosters without proportionate staff additions.

Ambulatory surgery centres log an expected 8.05% CAGR because insurers push for procedures that qualify for same-day discharge, cutting cost per case by up to 40%. Vendors respond with compact phaco machines and integrated sterilisation modules that fit space-constrained venues. Mobile eye units, often CSR funded, operate hub-and-spoke circuits that serve migration corridors, embedding rugged devices into rural delivery models across the Indian ophthalmic devices market.

Geography Analysis

Metropolitan clusters such as Mumbai, Bengaluru, Delhi-NCR, and Chennai collectively anchor more than half of Indian ophthalmic devices market revenue. These cities enjoy deeper insurance penetration, larger pools of ophthalmologists, and a consumer base willing to upgrade to premium intraocular lenses or pay out-of-pocket for FLACS. Eye-care chains consciously stage flagship centres in such metros to showcase technology, translating into a constant refresh cycle for microscopes, lasers, and diagnostic suites. At the same time, municipal governments run school-screening drives that raise baseline demand for autorefractors and handheld spot vision screeners.

Southern states occupy the innovation front line. Kerala’s Nayanamritham 2.0 programme links peripheral health workers to AI analytics that flag diabetic retinopathy and glaucoma in real time. Tamil Nadu’s long-standing universal health insurance covers cataract surgery at contracted private hospitals, ensuring regular volumes for consumable supply contracts. Startup incubators in Bengaluru and Hyderabad nurture hardware–software hybrids that suit Indian environments, boosting indigenous contribution to the Indian ophthalmic devices market.

Western states like Maharashtra and Gujarat ride corporate social responsibility (CSR) budgets that mobilise surgical buses into tribal districts. Reliance Foundation alone financed more than 545 cataract surgeries in FY 2023 through mobile camps, sustaining off-grid generators, compact anaesthesia carts, and rugged vitrectomy units. Such efforts seed familiarity with modern equipment among rural clinicians, priming future purchase cycles once district hospitals expand.

Northern, Central, and Northeastern regions present the steepest growth gradients. The Ayushman Bharat Digital Mission deploys a unified health-ID system that enables teleophthalmology consults for hill states and flood-prone plains. As road connectivity improves, distributors shorten delivery timelines for fragile items like green laser photocoagulators, making secondary towns viable sales targets. States such as Uttar Pradesh and Assam now ring-fence district budgets for vision-screening vans, creating first-time buyers in the Indian ophthalmic devices market. Over the forecast horizon, the convergence of central funding, telemedicine, and grassroots outreach is expected to flatten adoption disparities, but unique regional device mixes—battery life in arid zones, miniaturisation in hill terrain—will persist.

Competitive Landscape

Global manufacturers such as Alcon, Johnson & Johnson Vision Care, and Carl Zeiss Meditec secure enduring visibility through surgeon-training academies, broad distribution, and multi-modal portfolios. Alcon’s worldwide sales rose 8% in 2023 to USD 9.37 billion, and part of that growth came from customising mid-price phaco platforms for Indian procurement contracts. These incumbents enter value-sensitive tiers by launching compact workstations that share core optics with flagship lines but exclude premium automation, thereby protecting margin while defending their Indian ophthalmic devices market share.

Indigenous contenders, led by Remidio, Sankara Health Innovation, and Forus Health, deliver smartphone-integrated retinal cameras, low-cost OCT units, and AI screening engines that operate offline. Remidio’s Medios DR AI received CDSCO approval in 2024 and the company closed USD 25 million in venture funding, elevating its valuation to USD 67.5 million. Domestic innovation unlocks price points that Tier-III clinics can afford without sacrificing diagnostic accuracy, pulling latent demand into the formal channel. International brands react by exploring licensing or co-manufacturing deals to maintain relevance across the Indian ophthalmic devices market.

Service differentiation gains prominence. Hospital groups demand uptime guarantees above 95% and expect remote diagnostics to resolve minor glitches within 45 minutes. Vendors now house spare-part depots in eight logistics hubs instead of three, slashing turnaround times. Subscription-based maintenance contracts, once optional, become prerequisite for tender eligibility. As refurbishment quality improves, a price band emerges where certified pre-owned systems compete against new low-cost devices, adding complexity to market positioning decisions. By 2030, the combined share of the top five manufacturers is projected to hover near 55%, keeping the Indian ophthalmic devices market in the moderately fragmented zone where both global and local players can thrive.

India Ophthalmology Devices Industry Leaders

  1. Johnson & Johnson Vision Care

  2. Carl Zeiss Meditec AG

  3. Bausch + Lomb Corp.

  4. Alcon Inc.

  5. EssilorLuxottica SA

  6. *Disclaimer: Major Players sorted in no particular order
India Ophthalmology Devices Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • May 2025: Remidio received CDSCO approval for AI modules targeting glaucoma and age-related macular degeneration, expanding its regulatory-cleared portfolio.
  • April 2025: Dr Mohan’s Diabetes Specialities Center deployed an in-house AI algorithm that flags early retinal lesions during routine diabetes check-ups, raising screening coverage for its 350 000 patient base.
  • February 2025: Kerala launched Nayanamritham 2.0, India’s first state-wide AI eye-disease screening network, in partnership with Remidio and state health authorities.
  • October 2024: Remidio’s Medios DR AI, an offline diabetic-retinopathy solution, secured CDSCO clearance, permitting nationwide commercial rollout.

Table of Contents for India Ophthalmology Devices Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 National Program for Prevention & Control of Blindness (NPCB) Catalysing State-level Device Procurements
    • 4.2.2 Expansion of Ayushman Bharat Health Infrastructure Fund Driving Ophthalmic OT Up-grades
    • 4.2.3 Rapid Uptake of Femto-second Laser Assisted Cataract Surgery (FLACS) in Tier-I Cities
    • 4.2.4 Surge in Screen-induced Myopia Among 6-18 Year-olds Boosting Prescription Spectacles
    • 4.2.5 Growing Penetration of CSR-funded Mobile Eye-Surgery Camps in Rural West India
    • 4.2.6 Emergence of Indigenous Low-cost OCT & Fundus Cameras from Start-ups (e.g., Remidio)
  • 4.3 Market Restraints
    • 4.3.1 Shortage of Trained Vitreo-retinal Surgeons in Tier-II/III Cities
    • 4.3.2 High GST (12%) on Ophthalmic Capital Equipment Raising Cap-ex Barriers for Small Clinics
    • 4.3.3 Price-sensitive Consumer Base Limiting Adoption of Daily-Disposable Contact Lenses
    • 4.3.4 Fragmented After-sales Service Network Outside Metro Clusters
  • 4.4 Regulatory Outlook
  • 4.5 Porter's Five Forces Analysis
    • 4.5.1 Threat of New Entrants
    • 4.5.2 Bargaining Power of Buyers
    • 4.5.3 Bargaining Power of Suppliers
    • 4.5.4 Threat of Substitutes
    • 4.5.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Device Type
    • 5.1.1 Diagnostic & Monitoring Devices
    • 5.1.1.1 OCT Scanners
    • 5.1.1.2 Fundus & Retinal Cameras
    • 5.1.1.3 Autorefractors & Keratometers
    • 5.1.1.4 Corneal Topography Systems
    • 5.1.1.5 Ultrasound Imaging Systems
    • 5.1.1.6 Perimeters & Tonometers
    • 5.1.1.7 Other Diagnostic & Monitoring Devices
    • 5.1.2 Surgical Devices
    • 5.1.2.1 Cataract Surgical Devices
    • 5.1.2.2 Vitreoretinal Surgical Devices
    • 5.1.2.3 Refreactive Surgical Devices
    • 5.1.2.4 Glaucoma Surgical Devices
    • 5.1.2.5 Other Surgical Devices
    • 5.1.3 Vision Care Devices
    • 5.1.3.1 Spectacles Frames & Lenses
    • 5.1.3.2 Contact Lenses
  • 5.2 By Disease Indication
    • 5.2.1 Cataract
    • 5.2.2 Glaucoma
    • 5.2.3 Diabetic Retinopathy
    • 5.2.4 Other Disease Indications
  • 5.3 By End-user
    • 5.3.1 Hospitals
    • 5.3.2 Specialty Ophthalmic Clinics
    • 5.3.3 Ambulatory Surgery Centers (ASCs)
    • 5.3.4 Other End-users

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and analysis of Recent Developments)
    • 6.3.1 Alcon Inc.
    • 6.3.2 Johnson & Johnson Vision Care Inc.
    • 6.3.3 Bausch + Lomb Corp.
    • 6.3.4 EssilorLuxottica SA
    • 6.3.5 Carl Zeiss Meditec AG
    • 6.3.6 Hoya Corp.
    • 6.3.7 Topcon Corp.
    • 6.3.8 Nidek Co. Ltd.
    • 6.3.9 Appasamy Associates Private Limited
    • 6.3.10 Remidio Innovative Solutions Pvt Ltd.
    • 6.3.11 OmniLens Pvt Ltd.

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

India Ophthalmology Devices Market Report Scope

As per the scope of the report, ophthalmic devices are medical devices used in the identification and treatment of ocular defects or deficiencies and eye disorders. The ophthalmic devices are designed for diagnostics, surgical, and vision correction purposes. These devices are continuously gaining increased importance and adoption due to the high prevalence of various ophthalmic diseases, such as glaucoma, cataract, and other vision-related issues. The Indian Ophthalmology Devices market is segmented by Device (Surgical Device, Diagnostic and Monitoring Device, and Vision Care). The report offers the value (in USD million) for the above segments.

By Device Type Diagnostic & Monitoring Devices OCT Scanners
Fundus & Retinal Cameras
Autorefractors & Keratometers
Corneal Topography Systems
Ultrasound Imaging Systems
Perimeters & Tonometers
Other Diagnostic & Monitoring Devices
Surgical Devices Cataract Surgical Devices
Vitreoretinal Surgical Devices
Refreactive Surgical Devices
Glaucoma Surgical Devices
Other Surgical Devices
Vision Care Devices Spectacles Frames & Lenses
Contact Lenses
By Disease Indication Cataract
Glaucoma
Diabetic Retinopathy
Other Disease Indications
By End-user Hospitals
Specialty Ophthalmic Clinics
Ambulatory Surgery Centers (ASCs)
Other End-users
By Device Type
Diagnostic & Monitoring Devices OCT Scanners
Fundus & Retinal Cameras
Autorefractors & Keratometers
Corneal Topography Systems
Ultrasound Imaging Systems
Perimeters & Tonometers
Other Diagnostic & Monitoring Devices
Surgical Devices Cataract Surgical Devices
Vitreoretinal Surgical Devices
Refreactive Surgical Devices
Glaucoma Surgical Devices
Other Surgical Devices
Vision Care Devices Spectacles Frames & Lenses
Contact Lenses
By Disease Indication
Cataract
Glaucoma
Diabetic Retinopathy
Other Disease Indications
By End-user
Hospitals
Specialty Ophthalmic Clinics
Ambulatory Surgery Centers (ASCs)
Other End-users
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current Indian ophthalmic devices market size?

The market is valued at USD 1.59 billion for 2025.

How fast is the Indian ophthalmic devices industry expected to grow?

A CAGR of 6.91% is forecast for 2025-2030, taking the market to USD 2.21 billion by 2030.

Which device category holds the largest Indian ophthalmic devices market share?

Vision Care Devices lead with 63.71% share in 2024, driven by strong demand for spectacles and contact lenses.

Why are Diagnostic and Monitoring Devices growing rapidly?

AI integration and portable designs enable earlier disease detection, supporting a projected 9.03 % CAGR through 2030.

What regional markets show the highest growth potential?

Northern, Central, and Northeastern states demonstrate high upside due to expanding health infrastructure and tele-ophthalmology programmes.

How are indigenous manufacturers affecting competition?

Local start-ups offer cost-effective, AI-enabled equipment that forces multinational brands to recalibrate pricing and after-sales strategies, reshaping competitive dynamics.

Page last updated on: July 15, 2025

India Ophthalmology Devices Market Report Snapshots